EMA Authorised: Cufence (trientine dihydrochloride) — Univar Solutions BV

View source ↗

Summary

The EMA authorised Cufence (trientine dihydrochloride) from Univar Solutions BV for Wilson disease (hepatolenticular degeneration). The decision was issued on 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wilson Disease

Drugs mentioned

• Cufence (trientine dihydrochloride)

Snippet

Status: Authorised. Therapeutic area: Hepatolenticular Degeneration. MAH: Univar Solutions BV. Decision date: 25/06/2025